Acute and late toxicity in prostate cancer patients treated with moderately vs ultra-hypofractionated radiotherapy - Top-Institutions - MDSpire

Acute and late toxicity in prostate cancer patients treated with moderately vs ultra-hypofractionated radiotherapy

By
Javier Cifuentes-Quin
Yiselle T. Garcia-Montañez
Alexandra Hurtado-Ortiz
Jhonatan Cruz
Luis Carlos Lagares
Luis A. Olarte-Licht
Maricel Licht-Ardila
Edgar Fabián Manrique-Hernández
May 22, 2026

Frontiers In Oncology

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

#1

Colombian oncology center

Bogotá, Colombia
Key Differentiators
- Radiation Oncology
#2

national referral oncology center in Colombia

Bogotá, Colombia
Key Differentiators
- Radiation Oncology
#3

Duke University

Durham, North Carolina
Key Differentiators
- Radiation Oncology
#4

Skåne University Hospital

Lund, Sweden
Key Differentiators
- Radiation Oncology
#5

University of California, Los Angeles

Los Angeles, California
Key Differentiators
- Radiation Oncology

Original Source(s)

Frontiers In Oncology

Acute and late toxicity in prostate cancer patients treated with moderately vs ultra-hypofractionated radiotherapy

by Javier Cifuentes-Quin, Yiselle T. Garcia-Montañez, Alexandra Hurtado-Ortiz, Jhonatan Cruz, Luis Carlos Lagares, Luis A. Olarte-Licht, Maricel Licht-Ardila, Edgar Fabián Manrique-Hernández
May 22, 2026

Related Content

The Pathologist

Liquid Biopsy Supports Precision Oncology

Experts highlight clinical value, workflow integration, and real-world impact in lung and breast cancer diagnostics

May 22, 2026
8 min

The Pathologist

The CRISPR-powered Diagnostic SLEUTH

Novel DNA-guided system may support future RNA diagnostics and mutation detection

May 22, 2026
2 min

The Analytical Scientist

Vibe-Reporting Comes to Omics?

Jesse Meyer’s vibe-coded app is impressive, says Randall Julian, but don’t call it a “platform”

May 22, 2026
4 min